Related Experiment Video
Updated: Mar 11, 2026
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
First-Line Systemic Therapy for Non-Small Cell Lung Cancer
1Department of Thoracic Oncology, Massachusetts General Hospital, 32 Fruit Street, Yawkey 7B, Boston, MA 02114, USA.
Major advances in metastatic non-small cell lung cancer treatment include platinum-based chemotherapy, biologic agents like bevacizumab, and maintenance therapy, improving patient outcomes. Ongoing research aims to further refine first-line treatment strategies.
Area of Science:
- Oncology
- Medical treatment
Background:
- Metastatic non-small cell lung cancer (NSCLC) treatment has seen significant progress.
- Platinum-based combination therapy is the standard first-line treatment.
Purpose of the Study:
- To summarize recent advances in first-line treatment for metastatic non-small cell lung cancer.
- To highlight the role of biologic agents and maintenance therapy.
Main Methods:
- Review of current treatment strategies for metastatic non-small cell lung cancer.
- Analysis of the impact of biologic agents and maintenance therapy on patient outcomes.
Main Results:
- Platinum-based combination therapy remains a cornerstone treatment.
- Biologic agents (bevacizumab, necitumumab) offer benefits in selected populations.
- Maintenance therapy has improved overall survival in certain patient groups.
Conclusions:
- Current first-line treatments for metastatic non-small cell lung cancer have improved outcomes.
- Biologic agents and maintenance therapy are valuable additions to chemotherapy.
- Further research is ongoing to optimize first-line treatment strategies.
More Related Videos
05:17Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:56Treatment Resistant Cancers
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...